Preclinical Investigations of Intravitreal Ziv-Aflibercept

被引：33

作者：

de Oliveira Dias, Joao Rafael ^{[1
]}

Badaro, Emmerson ^{[1
]}

Novais, Eduardo Amorim ^{[1
]}

Colicchio, Daniel ^{[1
]}

Denadai Chiarantin, Gabrielly Maria ^{[2
]}

Matioli, Mariana Mauricio ^{[1
]}

Verna, Carina ^{[1
]}

Penha, Fernando Marcondes ^{[1
]}

Tenorio Barros, Nilana Meza ^{[2
]}

Meyer, Carsten H. ^{[1
]}

Farah, Michel Eid ^{[1
]}

Rodrigues, Eduardo Buchele ^{[1
]}

机构：

[1] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil

[2] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil

来源：

OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2014年 / 45卷 / 06期

关键词：

METASTATIC COLORECTAL-CANCER; VEGF TRAP-EYE; MACULAR DEGENERATION; RETINAL-DETACHMENT; IN-VITRO; BEVACIZUMAB; RANIBIZUMAB; INJECTION; DRUGS; NEOVASCULARIZATION;

D O I：

10.3928/23258160-20141118-15

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

BACKGROUND AND OBJECTIVE: To investigate the retinal safety of intravitreal (IVT) ziv-aflibercept in rabbits. MATERIALS AND METHODS: Eighteen rabbits were given an IVT injection of ziv-aflibercept (25 mg/mL) or aflibercept (40 mg/mL) and examined by funduscopy, electroretinography (ERG), optical coherence tomography (OCT), light microscopy, and transmission electron microscopy (TEM). Serum, aqueous, and vitreous were obtained afterward for osmolarity analysis. The effect of ziv-aflibercept on human retinal cultured cells (ARPE-19) was assessed by the MTT cell viability assay. RESULTS: All eyes showed normal funduscopy, OCT, and ERG findings at baseline and 24 hours or 7 days after the procedure. Median baseline serum, vitreous, and aqueous osmolarity remained unchanged. Histology and TEM showed no major anatomic signs of toxicity. No cytotoxic effect was observed in ARPE-19 cells exposed to ziv-aflibercept. CONCLUSION: IVT injection ziv-aflibercept at a concentration of 25 mg/mL proved to be safe for the rabbit retina.

引用

页码：577 / 584

页数：8

共 26 条

[1] THE EFFECTS OF AFLIBERCEPT ON THE VIABILITY AND METABOLISM OF OCULAR CELLS IN VITRO [J].

Ammar, David A. ;

Mandava, Naresh ;

Kahook, Malik Y. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (05) :1056-1061

[2]

Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198

[3] Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition? [J].

Browning, David J. ;

Kaiser, Peter K. ;

Rosenfeld, Philip J. ;

Stewart, Michael W. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (02) :222-226

[4] Molecularly targeted drugs for metastatic colorectal cancer [J].

Cheng, Ying-dong ;

Yang, Hua ;

Chen, Guo-qing ;

Zhang, Zhi-cao .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :1315-1322

[5] Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy [J].

de Oliveira Dias, Joao Rafael ;

Rodrigues, Eduardo Buechele ;

Maia, Mauricio ;

Magalhaes, Octaviano, Jr. ;

Penha, Fernando Marcondes ;

Farah, Michel Eid .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (12) :1631-1637

[6] Subretinal bevacizumab detection after intravitreous injection in rabbits [J].

Dib, Eduardo ;

Maia, Mauricio ;

Longo-Maugeri, Ieda Maria ;

Martins, Maria Cristina ;

Mussalem, Juliana Sekeres ;

Squaiella, Carla Cristina ;

Penha, Fernando M. ;

Magalhaes, Octaviano, Jr. ;

Rodrigues, Eduardo B. ;

Farah, Michel Eid .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (03) :1097-1100

[7] Ocular neovascularization: Basic mechanisms and therapeutic advances [J].

Dorrell, Michael ;

Uusitalo-Jarvinen, Hannele ;

Aguilar, Edith ;

Friedlander, Martin .

SURVEY OF OPHTHALMOLOGY, 2007, 52 :S3-S19

[8] Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].

Ferrara, N ;

Hillan, KJ ;

Gerber, HP ;

Novotny, W .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400

[9] Development of a Preclinical PK/PD Model to Assess Antitumor Response of a Sequential Aflibercept and Doxorubicin-Dosing Strategy in Acute Myeloid Leukemia [J].

Fetterly, Gerald J. ;

Aras, Urvi ;

Lal, Deepika ;

Murphy, Michael ;

Meholick, Patricia D. ;

Wang, Eunice S. .

AAPS JOURNAL, 2013, 15 (03) :662-673

[10] A preclinical and clinical review of aflibercept for the management of cancer [J].

Gaya, Andrew ;

Tse, Vivien .

CANCER TREATMENT REVIEWS, 2012, 38 (05) :484-493

← 1 2 3 →